Neurocrine Biosciences Inc (NBIX) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Neurocrine Biosciences Inc   (NASDAQ: NBIX)
 

Neurocrine Biosciences Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Neurocrine Biosciences Inc inventory turnover ratio, the Neurocrine Biosciences Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 0.89 in the second quarter 2026, NBIX's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Neurocrine Biosciences Inc in Jun 30 2026 quarter, has decreased to 410 days, compare to 420 days, in the Mar 31 2026 quarter.

Within Healthcare sector 325 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1283 in the first quarter 2026, to 1828.

NBIX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Neurocrine Biosciences Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NBIX Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 83.13 % 9.14 % 20.21 % 51.31 % 33.88 %
Y / Y Cost of Sales Growth 105.31 % 50 % 89.25 % 75 % 22.83 %
Inventory Turnover Ratio (TTM) 0.89 0.87 0.82 0.72 0.69
NBIX's Total Ranking # 1828 # 1283 # 479 # 458 # 1658
Average inventory processing period 408 418 445 506 529
Seq. Inventory Growth 61.55 % -6.52 % -0.43 % 21.79 % -3.72 %
Seq. Cost of Sales Growth 68.12 % -21.59 % 25.71 % 23.89 % 22.83 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 23
Healthcare Sector # 326
Overall Market # 1828

Inventory Turnover Ratio Statistics
High Average Low
1.21 0.73 0.43
(Sep 30 2023)   (Mar 31 2021)



NBIX Company Profile >> Back to NBIX Efficiency Comparisons >> Compare NBIX Inventory Turnover Ratio to its Competitors

Financial Statements
Neurocrine Biosciences Inc 's Inventories $ 104 Millions Visit NBIX's Balance sheet
Neurocrine Biosciences Inc 's Cost of Revenues TTM $ 69 Millions Visit NBIX's Income Statement
What are NBIX's Sales? Visit NBIX's Sales by Segment

Other Inventory Turnover Ratios
Neurocrine Biosciences Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
NBIX's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for NBIX's Competitors
Inventory Turnover Ratio for NBIX's Suppliers
Inventory Turnover Ratio for NBIX's Customers

You may also want to know
NBIX's Sales Growth Rates NBIX's Pe Price to earnings ratio NBIX's Receivables Turnover Ratio NBIX's Stock Quote
NBIX's Net Income Growth Rates NBIX's Ps Price to Sales ratio NBIX's Sales per Employee NBIX's Asset Turnover Ratio
NBIX's Net Margin NBIX's Pb Price to Book ratio NBIX's Financial Strength Ratios NBIX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Halozyme Therapeutics Inc   1.79 $ 292.421  Millions$ 164  Millions
Seastar Medical Holding Corp  1.78 $ 0.126  Millions$ 0  Millions
Alpha Pro Tech Ltd   1.76 $ 38.696  Millions$ 22  Millions
Tenet Healthcare Corp  1.76 $ 605.000  Millions$ 344  Millions
Tenon Medical Inc   1.76 $ 1.763  Millions$ 1  Millions
Iradimed Corporation  1.76 $ 20.839  Millions$ 12  Millions
Utah Medical Products Inc  1.75 $ 14.771  Millions$ 8  Millions
Elutia Inc   1.75 $ 4.337  Millions$ 2  Millions
Axsome Therapeutics Inc   1.73 $ 52.530  Millions$ 30  Millions
Vycor Medical Inc   1.72 $ 0.301  Millions$ 0  Millions
Harvard Bioscience Inc   1.71 $ 37.097  Millions$ 22  Millions
Quanterix Corporation  1.69 $ 87.760  Millions$ 52  Millions
Haemonetics Corporation  1.68 $ 553.577  Millions$ 329  Millions
Conmed Corporation  1.68 $ 606.349  Millions$ 362  Millions
Stryker Corp  1.67 $ 9,049.000  Millions$ 5,405  Millions
Atricure Inc   1.67 $ 134.975  Millions$ 81  Millions
Ceribell Inc   1.66 $ 11.159  Millions$ 7  Millions
The Cooper Companies Inc   1.65 $ 1,443.300  Millions$ 875  Millions
Procept Biorobotics Corporation  1.65 $ 120.119  Millions$ 73  Millions
Sanuwave Health Inc   1.62 $ 10.421  Millions$ 6  Millions
Bio rad Laboratories Inc   1.62 $ 1,245.200  Millions$ 769  Millions
Innovative Eyewear Inc   1.61 $ 2.634  Millions$ 2  Millions
Ultragenyx Pharmaceutical Inc   1.60 $ 87.336  Millions$ 55  Millions
Pfizer Inc  1.60 $ 17,084.000  Millions$ 10,684  Millions
Capsovision Inc   1.60 $ 5.736  Millions$ 4  Millions
Lakeland Industries Inc   1.59 $ 128.669  Millions$ 81  Millions
Integra Lifesciences Holdings Corp  1.59 $ 783.084  Millions$ 492  Millions
Ss Innovations International Inc  1.58 $ 28.689  Millions$ 18  Millions
Rapid Micro Biosystems Inc   1.57 $ 29.477  Millions$ 19  Millions
Urogen Pharma Ltd   1.54 $ 17.278  Millions$ 11  Millions

Date modified: 2026-08-31T07:05:19+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.